New Drug Combo Boosts Survival Against Aggressive Form of Breast Cancer
[ad_1] By Denise Mann HealthDay ReporterMONDAY, Sept. 20, 2021 (HealthDay News) -- New research offers good news for women with an aggressive HER2-positive breast cancer. A targeted therapy, trastuzumab deruxtecan...
Read More >
